Expanding TKI Therapy in Advanced Lung Cancer – OncLive

by lowes1 on October 9, 2013


OncLive
Expanding TKI Therapy in Advanced Lung Cancer
OncLive
Amid rapid progress in the treatment of advanced lung cancer, several leading organizations have joined in developing new guidelines for the optimal use of molecular testing to help select patients for therapy with tyrosine kinase inhibitors (TKIs).1

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: